159 related articles for article (PubMed ID: 22890131)
1. Regulatory T cells inhibit CD8(+) T-cell tissue invasion in human skin graft-versus-host reactions.
Mavin E; Ahmed SS; O'Boyle G; Turner B; Douglass S; Norden J; Collin M; Ali S; Dickinson A; Wang XN
Transplantation; 2012 Sep; 94(5):456-64. PubMed ID: 22890131
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M
Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707
[TBL] [Abstract][Full Text] [Related]
4. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
[TBL] [Abstract][Full Text] [Related]
5. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
Lin Q; Song Y; Zhu X; Yang S; Zheng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
[TBL] [Abstract][Full Text] [Related]
7. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
Santodomingo-Garzon T; Han J; Le T; Yang Y; Swain MG
Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218
[TBL] [Abstract][Full Text] [Related]
8. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K
J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
10. Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR.
Mapara MY; Leng C; Kim YM; Bronson R; Lokshin A; Luster A; Sykes M
Biol Blood Marrow Transplant; 2006 Jun; 12(6):623-34. PubMed ID: 16737935
[TBL] [Abstract][Full Text] [Related]
11. CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease.
Villarroel VA; Okiyama N; Tsuji G; Linton JT; Katz SI
J Invest Dermatol; 2014 Jun; 134(6):1552-1560. PubMed ID: 24390137
[TBL] [Abstract][Full Text] [Related]
12. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
[TBL] [Abstract][Full Text] [Related]
13. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
Stanford MM; Issekutz TB
J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
[TBL] [Abstract][Full Text] [Related]
14. Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.
Zheng J; Liu Y; Qin G; Lam KT; Guan J; Xiang Z; Lewis DB; Lau YL; Tu W
Eur J Immunol; 2011 Jan; 41(1):128-39. PubMed ID: 21182084
[TBL] [Abstract][Full Text] [Related]
15. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
16. Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: Involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor.
Lisignoli G; Toneguzzi S; Piacentini A; Cristino S; Cattini L; Grassi F; Facchini A
J Cell Physiol; 2004 Mar; 198(3):388-98. PubMed ID: 14755544
[TBL] [Abstract][Full Text] [Related]
17. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma.
Ohtani H; Jin Z; Takegawa S; Nakayama T; Yoshie O
J Pathol; 2009 Jan; 217(1):21-31. PubMed ID: 18980207
[TBL] [Abstract][Full Text] [Related]
18. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs.
Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M
Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452
[TBL] [Abstract][Full Text] [Related]
19. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Shimizu T; Tada Y; Watanabe S
Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
[TBL] [Abstract][Full Text] [Related]
20. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
Müller M; Carter S; Hofer MJ; Campbell IL
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
